SCHEMBL7033559

SCHEMBL7033559

c1ccc2[nH]c(NC3=NCCN3)nc2c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 2/20 0.57
CYP1A2 P05177 1/20 0.57
NPC1 O15118 5/20 0.54
RAB9A P51151 5/20 0.54
SMN1; SMN2 Q16637 4/20 0.54
MEN1 O00255 3/20 0.54
KMT2A Q03164 3/20 0.54
ALDH1A1 P00352 1/20 0.54
HPGD P15428 1/20 0.54
LMNA P02545 3/20 0.52
ADRA2A P08913 7/20 0.50
GAA P10253 1/20 0.50
ADRA2B P18089 5/20 0.49
ADRA2C P18825 5/20 0.49
MAPT P10636 2/20 0.49
ADRA1D P25100 2/20 0.48
ADRA1A P35348 2/20 0.48
ADRA1B P35368 2/20 0.48
TP53 P04637 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL10353910 0.98 ALOX15 (0.56) ALOX15CYP1A2NPC1RAB9ASMN1; SMN2
SCHEMBL11785192 0.80 ADRA2A (0.43) ALOX15CYP1A2NPC1RAB9ASMN1; SMN2
SCHEMBL11787434 0.80 HTR1D (0.46) ALOX15CYP1A2NPC1RAB9ASMN1; SMN2
SCHEMBL11785989 0.80 POLB (0.50) CYP1A2NPC1RAB9ASMN1; SMN2MEN1
SCHEMBL11785205 0.80 ADRA2A (0.45) CYP1A2NPC1RAB9ASMN1; SMN2MEN1
SCHEMBL11783011 0.80 ADRA2A (0.46) NPC1RAB9ASMN1; SMN2MEN1KMT2A
SCHEMBL11787437 0.80 HTR1D (0.46) ALOX15CYP1A2NPC1RAB9ASMN1; SMN2
Water SCHEMBL11782383 0.80 ADRA2A (0.45) CYP1A2NPC1RAB9ASMN1; SMN2MEN1
SCHEMBL11786023 0.80 ADRA2A (0.47) ADRA2AADRA2BADRA2CADRA1DADRA1A
Water SCHEMBL11782373 0.80 ADRA2A (0.43) ALOX15CYP1A2NPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030022927-A1 Novel benzimidazole derivatives SYNAPTIC PHARMACEUTICAL CORPORATION 2003-01-30 US disclosed
EP-0775134-A1 Imidazolin-2-ylaminobenzimidazole derivatives SYNAPTIC PHARMACEUTICAL CORPORATION (US) 1997-05-28 EP disclosed
US-3935314-A Anti-hypertensive compositions of benzimidazole derivatives BEECHAM GROUP LIMITED (EN) 1976-01-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030022927-A1 Novel benzimidazole derivatives OPRL1, OPRD1, OPRM1 ALOX15 3708/4885CYP1A2 620/4885NPC1 1109/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.